Intelligent Ultrasound Limited – Wins Best Emerging Medtech Company Award at OBN Annual Awards

October 3, 2014 -

Intelligent Ultrasound Limited, a leader in imaging analytics, won the award for Best Emerging Medtech Company at the prestigious OBN Annual Awards dinner, held yesterday evening at the Ashmolean Museum in Oxford.

The Company, spun out of the University of Oxford in July 2012, sells its Intelligent Quality Analytics (IQA) service to providers of ultrasound imaging services. The Company’s technology aims to improve the reliability and timeliness of diagnosis for patients requiring ultrasound scans.

This goal will be achieved by making possible (for the first time) comprehensive, independent audit of the completeness and quality of ultrasound scans, allowing providers of ultrasound services systematically to identify and address staff training needs.

The Company’s IQA service is expected to improve the quality, efficiency and cost-effectiveness of ultrasound imaging – the most widely used imaging technique in medicine.

For further information:
Andy Hill (CEO) Intelligent Ultrasound Limited
01235 841556

Notes for editors:
Intelligent Ultrasound’s vision is to ensure that every patient who could benefit from a diagnosis using medical imaging gets the best possible scan so that doctors can make fully informed diagnoses quickly and begin treating patients at the earliest possible time.

Intelligent Ultrasound was spun out of the University of Oxford’s Institute of Biomedical Engineering (IBME) in July 2012. The technology underpinning the company’s core products was the brainchild of Alison Noble, OBE FREng, Technikos Professor of Biomedical Engineering at the IBME. Alison is a world expert in the computer vision and machine learning techniques that Intelligent Ultrasound’s products and services are built on.

The Company’s clinical advisor is Dr Aris Papageorghiou, a consultant obstetrician and expert in ultrasound image quality control and imaging protocol development. The Company’s management team is led by Andrew Barker (Chairman) and Andy Hill (CEO).

The Company has raised a total of £2.2m in equity finance, including an investment of £200k from the National Health Service’s National Innovation Centre. In addition the Company has secured grant funding to the value of £560k from the Technology Strategy Board.